Protracted abstinence from distinct drugs of abuse shows regulation of a common gene network

Addiction Biology

Volumn 17, Issue 1, 2012, Pages 1-12

  Le Merrer, Julie ^a,b   Befort, Katia ^a,b   Gardon, Olivier ^a,b   Filliol, Dominique ^a,b   Darcq, Emmanuel ^a,b   Dembele, Doulaye ^a,b   Becker, Jerome A J ^a,b   Kieffer, Brigitte L ^a,b  

^a CNRS   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Abstinence; addiction; extended amygdala; gene expression; medium spiny neurons; mu opioid receptor

Indexed keywords

ALCOHOL; DRONABINOL; HUNTINGTIN; MORPHINE; NICOTINE;

ADAPTATION; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; DRUG WITHDRAWAL; DYNAMICS; GENE; GENE CONTROL; MALE; MEDICAL LITERATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AMYGDALA; ANIMALS; BEHAVIOR, ADDICTIVE; BRAIN; CLUSTER ANALYSIS; DISEASE MODELS, ANIMAL; ETHANOL; GENE EXPRESSION; GENE REGULATORY NETWORKS; MALE; MICE; MICE, INBRED C57BL; MORPHINE; NICOTINE; PRINCIPAL COMPONENT ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, OPIOID, MU; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS; TEMPERANCE; TETRAHYDROCANNABINOL; TIME; TRANSCRIPTIONAL ACTIVATION;

EID: 84355166646     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/j.1369-1600.2011.00365.x     Document Type: Article

References (98)

1. Ahmed SH, Lutjens R, van der Stap LD, Lekic D, Romano-Spica V, Morales M, Koob GF, Repunte-Canonigo V, Sanna PP, (2005) Gene expression evidence for remodeling of lateral hypothalamic circuitry in cocaine addiction. Proc Natl Acad Sci USA 102: 11533-11538. (Pubitemid 41153854)
2. Alheid GF, Heimer L, (1988) New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: the striatopallidal, amygdaloid, and corticopetal components of substantia innominata. Neuroscience 27: 1-39.
3. Arlotta P, Molyneaux BJ, Jabaudon D, Yoshida Y, Macklis JD, (2008) Ctip2 controls the differentiation of medium spiny neurons and the establishment of the cellular architecture of the striatum. J Neurosci 28: 622-632. (Pubitemid 351159027)
4. Artero-Castro A, Callejas FB, Castellvi J, Kondoh H, Carnero A, Fernandez-Marcos PJ, Serrano M, Ramon y Cajal S, Lleonart ME, (2009) Cold-inducible RNA-binding protein bypasses replicative senescence in primary cells through extracellular signal-regulated kinase 1 and 2 activation. Mol Cell Biol 29: 1855-1868.
5. Baler RD, Volkow ND, (2006) Drug addiction: the neurobiology of disrupted self-control. Trends Mol Med 12: 559-566. (Pubitemid 44780200)
6. Batel P, Houchi H, Daoust M, Ramoz N, Naassila M, Gorwood P, (2008) A haplotype of the DRD1 gene is associated with alcohol dependence. Alcohol Clin Exp Res 32: 567-572. (Pubitemid 351430427)
7. Becker JA, Befort K, Blad C, Filliol D, Ghate A, Dembele D, Thibault C, Koch M, Muller J, Lardenois A, Poch O, Kieffer BL, (2008) Transcriptome analysis identifies genes with enriched expression in the mouse central extended amygdala. Neuroscience 156: 950-965.
8. Befort K, Filliol D, Ghate A, Darcq E, Matifas A, Muller J, Lardenois A, Thibault C, Dembele D, Le Merrer J, Becker JA, Poch O, Kieffer BL, (2008) Mu-opioid receptor activation induces transcriptional plasticity in the central extended amygdala. Eur J Neurosci 27: 2973-2984. (Pubitemid 351832223)
9. Bell-Horner CL, Dohi A, Nguyen Q, Dillon GH, Singh M, (2006) ERK/MAPK pathway regulates GABAA receptors. J Neurobiol 66: 1467-1474. (Pubitemid 44715754)
10. Berrendero F, Kieffer BL, Maldonado R, (2002) Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in mu-opioid receptor knock-out mice. J Neurosci 22: 10935-10940. (Pubitemid 36005169)
11. Blain JF, Paradis E, Gaudreault SB, Champagne D, Richard D, Poirier J, (2004) A role for lipoprotein lipase during synaptic remodeling in the adult mouse brain. Neurobiol Dis 15: 510-519. (Pubitemid 38429965)
12. Briand LA, Blendy JA, (2009) Molecular and genetic substrates linking stress and addiction. Brain Res 1314: 219-234.
13. Brown RM, Short JL, (2008) Adenosine A(2A) receptors and their role in drug addiction. J Pharm Pharmacol 60: 1409-1430.
14. Burre J, Zimmermann H, Volknandt W, (2007) Identification and characterization of SV31, a novel synaptic vesicle membrane protein and potential transporter. J Neurochem 103: 276-287. (Pubitemid 47404221)
15. Cahoy JD, Emery B, Kaushal A, Foo LC, Zamanian JL, Christopherson KS, Xing Y, Lubischer JL, Krieg PA, Krupenko SA, Thompson WJ, Barres BA, (2008) A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J Neurosci 28: 264-278.
16. Capasso A, (2001) Involvement of nuclear factor-kB in the expression of opiate withdrawal. Prog Neuropsychopharmacol Biol Psychiatry 25: 1259-1268. (Pubitemid 32835283)
17. Caporaso GL, Bibb JA, Snyder GL, Valle C, Rakhilin S, Fienberg AA, Hemmings HC, Nairn AC, Greengard P, (2000) Drugs of abuse modulate the phosphorylation of ARPP-21, a cyclic AMP-regulated phosphoprotein enriched in the basal ganglia. Neuropharmacology 39: 1637-1644. (Pubitemid 30330880)
18. Cassell MD, Freedman LJ, Shi C, (1999) The intrinsic organization of the central extended amygdala. Ann N Y Acad Sci 877: 217-241. (Pubitemid 29351860)
19. Castane A, Robledo P, Matifas A, Kieffer BL, Maldonado R, (2003) Cannabinoid withdrawal syndrome is reduced in double mu and delta opioid receptor knockout mice. Eur J Neurosci 17: 155-159. (Pubitemid 36098886)
20. Chen LC, Liu HP, Li HP, Hsueh C, Yu JS, Liang CL, Chang YS, (2009) Thymidine phosphorylase mRNA stability and protein levels are increased through ERK-mediated cytoplasmic accumulation of hnRNP K in nasopharyngeal carcinoma cells. Oncogene 28: 1904-1915.
21. Ciruela F, Casado V, Rodrigues RJ, Lujan R, Burgueno J, Canals M, Borycz J, Rebola N, Goldberg SR, Mallol J, Cortes A, Canela EI, Lopez-Gimenez JF, Milligan G, Lluis C, Cunha RA, Ferre S, Franco R, (2006) Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers. J Neurosci 26: 2080-2087.
22. Contet C, Gardon O, Filliol D, Becker JAJ, Koob GF, Kieffer BL, (2011) Identification of genes regulated in the mouse extended amygdala by excessive ethanol drinking associated with dependence. Addict Biol doi: 10.1111/j.1369-1600.2010.00304.x. [Epub ahead of print].
23. Contet C, Kieffer BL, Befort K, (2004) Mu opioid receptor: a gateway to drug addiction. Curr Opin Neurobiol 14: 370-378. (Pubitemid 38759868)
24. Eisen MB, Spellman PT, Brown PO, Botstein D, (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95: 14863-14868. (Pubitemid 29003722)
25. Everitt BJ, Robbins TW, (2005) Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 8: 1481-1489. (Pubitemid 41573659)
26. Fernandez E, Collins MO, Uren RT, Kopanitsa MV, Komiyama NH, Croning MD, Zografos L, Armstrong JD, Choudhary JS, Grant SG, (2009) Targeted tandem affinity purification of PSD-95 recovers core postsynaptic complexes and schizophrenia susceptibility proteins. Mol Syst Biol 5: 269.
27. Gerfen CR, (1992) The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. Annu Rev Neurosci 15: 285-320.
28. Gilbert F, Morissette MS, Hilaire M, Paquet B, Rouillard C, Di Paolo T, Levesque D, (2006) Nur77 gene knockout alters dopamine neuron biochemical activity and dopamine turnover. Biol Psychiatry 60: 538-547. (Pubitemid 44402380)
29. Goeldner C, Lutz PE, Darcq E, Halter T, Clesse D, Ouagazzal AM, Kieffer BL, (2011) Impaired emotional-like behavior and serotonergic function during protracted abstinence from chronic morphine. Biol Psychiatry 69: 236-244.
30. Goudreault M, D'Ambrosio LM, Kean MJ, Mullin MJ, Larsen BG, Sanchez A, Chaudhry S, Chen GI, Sicheri F, Nesvizhskii AI, Aebersold R, Raught B, Gingras AC, (2009) A PP2A phosphatase high density interaction network identifies a novel striatin-interacting phosphatase and kinase complex linked to the cerebral cavernous malformation 3 (CCM3) protein. Mol Cell Proteomics 8: 157-171.
31. Hasue RH, Shammah-Lagnado SJ, (2002) Origin of the dopaminergic innervation of the central extended amygdala and accumbens shell: a combined retrograde tracing and immunohistochemical study in the rat. J Comp Neurol 454: 15-33. (Pubitemid 35278452)
32. Healy NC, O'Connor R, (2009) Sequestration of PDLIM2 in the cytoplasm of monocytic/macrophage cells is associated with adhesion and increased nuclear activity of NF-kappaB. J Leukoc Biol 85: 481-490.
33. Hohmann AG, Herkenham M, (1999) Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study. Neuroscience 90: 923-931. (Pubitemid 29156757)
34. Hokfelt T, Xu ZQ, Shi TJ, Holmberg K, Zhang X, (1998) Galanin in ascending systems. Focus on coexistence with 5-hydroxytryptamine and noradrenaline. Ann N Y Acad Sci 863: 252-263. (Pubitemid 29047780)
35. de Hoon MJ, Imoto S, Nolan J, Miyano S, (2004) Open source clustering software. Bioinformatics 20: 1453-1454. (Pubitemid 38931415)
36. Hosoki K, Kagami M, Tanaka T, Kubota M, Kurosawa K, Kato M, Uetake K, Tohyama J, Ogata T, Saitoh S, (2009) Maternal uniparental disomy 14 syndrome demonstrates Prader-Willi syndrome-like phenotype. J Pediatr 155: 900-903 e901.
37. Huang W, Ma JZ, Payne TJ, Beuten J, Dupont RT, Li MD, (2008) Significant association of DRD1 with nicotine dependence. Hum Genet 123: 133-140.
38. Ito H, Yamamoto N, Arima H, Hirate H, Morishima T, Umenishi F, Tada T, Asai K, Katsuya H, Sobue K, (2006) Interleukin-1beta induces the expression of aquaporin-4 through a nuclear factor-kappaB pathway in rat astrocytes. J Neurochem 99: 107-118. (Pubitemid 44395134)
39. Ivkovic S, Ehrlich ME, (1999) Expression of the striatal DARPP-32/ARPP-21 phenotype in GABAergic neurons requires neurotrophins in vivo and in vitro. J Neurosci 19: 5409-5419. (Pubitemid 29300206)
40. Jo K, Derin R, Li M, Bredt DS, (1999) Characterization of MALS/Velis-1, -2, and -3: a family of mammalian LIN-7 homologs enriched at brain synapses in association with the postsynaptic density-95/NMDA receptor postsynaptic complex. J Neurosci 19: 4189-4199. (Pubitemid 29241073)
41. Jolliffe I, (2004) Principal Component Analysis, 2nd edn. New York: Springer.
42. Kalivas PW, (2009) The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci 10: 561-572.
43. Kalivas PW, Hu XT, (2006) Exciting inhibition in psychostimulant addiction. Trends Neurosci 29: 610-616. (Pubitemid 44602258)
44. Kang SS, Cole M, Lee S, Rivier C, (2004) Development of individual alcohol inhalation chambers for mice: validation in a model of prenatal alcohol. Alcohol Clin Exp Res 28: 1549-1556. (Pubitemid 39390477)
45. Kapp-Barnea Y, Ninio-Many L, Hirschberg K, Fukuda M, Jeromin A, Sagi-Eisenberg R, (2006) Neuronal calcium sensor-1 and phosphatidylinositol 4-kinase beta stimulate extracellular signal-regulated kinase 1/2 signaling by accelerating recycling through the endocytic recycling compartment. Mol Biol Cell 17: 4130-4141. (Pubitemid 44330894)
46. Kauer JA, Malenka RC, (2007) Synaptic plasticity and addiction. Nat Rev Neurosci 8: 844-858. (Pubitemid 350006216)
47. Kim S, Burette A, Chung HS, Kwon SK, Woo J, Lee HW, Kim K, Kim H, Weinberg RJ, Kim E, (2006) NGL family PSD-95-interacting adhesion molecules regulate excitatory synapse formation. Nat Neurosci 9: 1294-1301. (Pubitemid 44454271)
48. Koob GF, (2008) A role for brain stress systems in addiction. Neuron 59: 11-34. (Pubitemid 351905857)
49. Koob GF, (2009) Brain stress systems in the amygdala and addiction. Brain Res 1293: 61-75.
50. Koob GF, Le Moal M, (2008) Addiction and the brain antireward system. Annu Rev Psychol 59: 29-53.
51. Kuhn A, Goldstein DR, Hodges A, Strand AD, Sengstag T, Kooperberg C, Becanovic K, Pouladi MA, Sathasivam K, Cha JH, Hannan AJ, Hayden MR, Leavitt BR, Dunnett SB, Ferrante RJ, Albin R, Shelbourne P, Delorenzi M, Augood SJ, Faull RL, Olson JM, Bates GP, Jones L, Luthi-Carter R, (2007) Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage. Hum Mol Genet 16: 1845-1861. (Pubitemid 47244533)
52. Kuntz-Melcavage KL, Brucklacher RM, Grigson PS, Freeman WM, Vrana KE, (2009) Gene expression changes following extinction testing in a heroin behavioral incubation model. BMC Neurosci 10: 95.
53. Le Foll B, Gallo A, Le Strat Y, Lu L, Gorwood P, (2009) Genetics of dopamine receptors and drug addiction: a comprehensive review. Behav Pharmacol 20: 1-17.
54. Le Merrer J, Becker JA, Befort K, Kieffer BL, (2009) Reward processing by the opioid system in the brain. Physiol Rev 89: 1379-1412.
55. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25: 402-408. (Pubitemid 34164012)
56. Logue SF, Grauer SM, Paulsen J, Graf R, Taylor N, Sung MA, Zhang L, Hughes Z, Pulito VL, Liu F, Rosenzweig-Lipson S, Brandon NJ, Marquis KL, Bates B, Pausch M, (2009) The orphan GPCR, GPR88, modulates function of the striatal dopamine system: a possible therapeutic target for psychiatric disorders? Mol Cell Neurosci 42: 438-447.
57. Maldonado R, Valverde O, Berrendero F, (2006) Involvement of the endocannabinoid system in drug addiction. Trends Neurosci 29: 225-232.
58. Marsicano G, Lutz B, (1999) Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur J Neurosci 11: 4213-4225. (Pubitemid 30009252)
59. Massart R, Guilloux JP, Mignon V, Sokoloff P, Diaz J, (2009) Striatal GPR88 expression is confined to the whole projection neuron population and is regulated by dopaminergic and glutamatergic afferents. Eur J Neurosci 30: 397-414.
60. McBride WJ, Kimpel MW, Schultz JA, McClintick JN, Edenberg HJ, Bell RL, (2010) Changes in gene expression in regions of the extended amygdala of alcohol-preferring rats after binge-like alcohol drinking. Alcohol 44: 171-183.
61. McClung CA, Nestler EJ, (2008) Neuroplasticity mediated by altered gene expression. Neuropsychopharmacology 33: 3-17. (Pubitemid 350191310)
62. McDonald AJ, (2003) Is there an amygdala and how far does it extend? An anatomical perspective. Ann N Y Acad Sci 985: 1-21. (Pubitemid 36521101)
63. McMahon FJ, Akula N, Schulze TG, Muglia P, Tozzi F, Detera-Wadleigh SD, Steele CJ, Breuer R, Strohmaier J, Wendland JR, Mattheisen M, Muhleisen TW, Maier W, Nothen MM, Cichon S, Farmer A, Vincent JB, Holsboer F, Preisig M, Rietschel M, (2010) Meta-analysis of genome-wide association data identifies a risk locus for major mood disorders on 3p21.1. Nat Genet 42: 128-131.
64. Menniti FS, Chappie TA, Humphrey JM, Schmidt CJ, (2007) Phosphodiesterase 10A inhibitors: a novel approach to the treatment of the symptoms of schizophrenia. Curr Opin Investig Drugs 8: 54-59. (Pubitemid 46438266)
65. Mercer EA, Korhonen L, Skoglosa Y, Olsson PA, Kukkonen JP, Lindholm D, (2000) NAIP interacts with hippocalcin and protects neurons against calcium-induced cell death through caspase-3-dependent and -independent pathways. EMBO J 19: 3597-3607. (Pubitemid 30462118)
66. Mitchell P, Selbie L, Waters B, Donald J, Vivero C, Tully M, Shine J, (1992) Exclusion of close linkage of bipolar disorder to dopamine D1 and D2 receptor gene markers. J Affect Disord 25: 1-11.
67. Nestler EJ, (2001) Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2: 119-128. (Pubitemid 33673366)
68. Nestler EJ, (2005) Is there a common molecular pathway for addiction? Nat Neurosci 8: 1445-1449. (Pubitemid 41573654)
69. O'Brien CP, (1997) A range of research-based pharmacotherapies for addiction. Science 278: 66-70. (Pubitemid 27446273)
70. O'Brien CP, (2008) Review. Evidence-based treatments of addiction. Philos Trans R Soc Lond B Biol Sci 363: 3277-3286.
71. Oh ES, Woods A, Couchman JR, (1997) Multimerization of the cytoplasmic domain of syndecan-4 is required for its ability to activate protein kinase C. J Biol Chem 272: 11805-11811. (Pubitemid 27202748)
72. Okvist A, Johansson S, Kuzmin A, Bazov I, Merino-Martinez R, Ponomarev I, Mayfield RD, Harris RA, Sheedy D, Garrick T, Harper C, Hurd YL, Terenius L, Ekstrom TJ, Bakalkin G, Yakovleva T, (2007) Neuroadaptations in human chronic alcoholics: dysregulation of the NF-kappaB system. PLoS ONE 2: e930.
73. de Olmos JS, Heimer L, (1999) The concepts of the ventral striatopallidal system and extended amygdala. Ann N Y Acad Sci 877: 1-32. (Pubitemid 29351848)
74. Ouimet CC, Hemmings HC, Jr, Greengard P, (1989) ARPP-21, a cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions. II. Immunocytochemical localization in rat brain. J Neurosci 9: 865-875. (Pubitemid 19085872)
75. Paterlini M, Revilla V, Grant AL, Wisden W, (2000) Expression of the neuronal calcium sensor protein family in the rat brain. Neuroscience 99: 205-216. (Pubitemid 30628408)
76. Paxinos G, Franklin K, (2001) The Mouse Brain in Stereotaxic Coordinates, 2nd edn. San Diego: Academic Press.
77. Piechota M, Korostynski M, Solecki W, Gieryk A, Slezak M, Bilecki W, Ziolkowska B, Kostrzewa E, Cymerman I, Swiech L, Jaworski J, Przewlocki R, (2010) The dissection of transcriptional modules regulated by various drugs of abuse in the mouse striatum. Genome Biol 11: R48.
78. Poulin JF, Chevalier B, Laforest S, Drolet G, (2006) Enkephalinergic afferents of the centromedial amygdala in the rat. J Comp Neurol 496: 859-876.
79. Ramia NF, Kreydiyyeh SI, (2009) TNF-alpha modulates the Na+/K+ ATPase and the Na+K+2Cl- symporter in LLC-PK cells. Eur J Clin Invest 39: 280-288.
80. Rehni AK, Bhateja P, Singh TG, Singh N, (2008) Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome. Behav Pharmacol 19: 265-269. (Pubitemid 351670407)
81. Rhodes JS, Crabbe JC, (2005) Gene expression induced by drugs of abuse. Curr Opin Pharmacol 5: 26-33. (Pubitemid 40124531)
82. Russo SJ, Mazei-Robison MS, Ables JL, Nestler EJ, (2009) Neurotrophic factors and structural plasticity in addiction. Neuropharmacology 56 (Suppl 1): 73-82.
83. Sakurai T, Itoh K, Higashitsuji H, Nonoguchi K, Liu Y, Watanabe H, Nakano T, Fukumoto M, Chiba T, Fujita J, (2006) Cirp protects against tumor necrosis factor-alpha-induced apoptosis via activation of extracellular signal-regulated kinase. Biochim Biophys Acta 1763: 290-295.
84. Sanchis-Segura C, Cline B, Jurd R, Rudolph U, Spanagel R, (2007) Etomidate and propofol-hyposensitive GABAA receptor beta3(N265M) mice show little changes in acute alcohol sensitivity but enhanced tolerance and withdrawal. Neurosci Lett 416: 275-278. (Pubitemid 46483867)
85. Secolin R, Banzato CE, Oliveira MC, Bittar MF, Santos ML, Dalgalarrondo P, Lopes-Cendes I, (2010) Family-based association study for bipolar affective disorder. Psychiatr Genet 20: 126-129.
86. Shaham Y, Shalev U, Lu L, De Wit H, Stewart J, (2003) The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berl) 168: 3-20. (Pubitemid 36851158)
87. Shalev U, Grimm JW, Shaham Y, (2002) Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev 54: 1-42. (Pubitemid 34208828)
88. Smith RJ, Aston-Jones G, (2008) Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinence. Brain Struct Funct 213: 43-61.
89. Spijker S, Houtzager SW, De Gunst MC, De Boer WP, Schoffelmeer AN, Smit AB, (2004) Morphine exposure and abstinence define specific stages of gene expression in the rat nucleus accumbens. FASEB J 18: 848-850.
90. Stephens DN, Duka T, (2008) Review. Cognitive and emotional consequences of binge drinking: role of amygdala and prefrontal cortex. Philos Trans R Soc Lond B Biol Sci 363: 3169-3179.
91. St-Hilaire M, Landry E, Levesque D, Rouillard C, (2003) Denervation and repeated L-DOPA induce a coordinate expression of the transcription factor NGFI-B in striatal projection pathways in hemi-parkinsonian rats. Neurobiol Dis 14: 98-109. (Pubitemid 37103184)
92. St-Hilaire M, Landry E, Levesque D, Rouillard C, (2005) Denervation and repeated L-DOPA induce complex regulatory changes in neurochemical phenotypes of striatal neurons: implication of a dopamine D1-dependent mechanism. Neurobiol Dis 20: 450-460. (Pubitemid 41476271)
93. Surmeier DJ, Song WJ, Yan Z, (1996) Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. J Neurosci 16: 6579-6591. (Pubitemid 26337379)
94. Tamura S, Morikawa Y, Iwanishi H, Hisaoka T, Senba E, (2004) Foxp1 gene expression in projection neurons of the mouse striatum. Neuroscience 124: 261-267. (Pubitemid 38229647)
95. Uhart M, Wand GS, (2009) Stress, alcohol and drug interaction: an update of human research. Addict Biol 14: 43-64.
96. Waraczynski MA, (2006) The central extended amygdala network as a proposed circuit underlying reward valuation. Neurosci Biobehav Rev 30: 472-496.
97. Yau JL, McNair KM, Noble J, Brownstein D, Hibberd C, Morton N, Mullins JJ, Morris RG, Cobb S, Seckl JR, (2007) Enhanced hippocampal long-term potentiation and spatial learning in aged 11beta-hydroxysteroid dehydrogenase type 1 knock-out mice. J Neurosci 27: 10487-10496. (Pubitemid 47502008)
98. Zuo L, Kranzler HR, Luo X, Covault J, Gelernter J, (2007) CNR1 variation modulates risk for drug and alcohol dependence. Biol Psychiatry 62: 616-626. (Pubitemid 47314382)